Show simple item record

dc.contributor.authorWorld Health Organization. Biologicals Uniten
dc.contributor.authorKokuritsu Kansensho Kenkyujo (‎Japan)‎en
dc.contributor.authorHayashibara Biochemical Laboratoriesen
dc.contributor.authorMochida Pharmaceutical Coen
dc.contributor.authorOtsuka Phamaceutical Coen
dc.contributor.authorSumitomo Pharmaceuticals Coen
dc.contributor.authorWHO Expert Committee on Biological Standardization (‎2003 : Geneva, Switzerland)‎en
dc.coverage.spatialGeneva
dc.date.accessioned2012-06-17T01:01:57Z
dc.date.available2012-06-17T01:01:57Z
dc.date.created2003en
dc.date.issued2003en
dc.identifier.govdocWHO/BS/03.1982en
dc.identifier.urihttps://apps.who.int/iris/handle/10665/68387
dc.descriptionDiscontinuity in the unitage for HulFN-N1(‎Human Lymphoblastoid IFN)‎en
dc.descriptionPresented at the meeting of the Expert Committee on Biological Standardization, Geneva, 17 to 21 November 2003en
dc.descriptionWHO/BS/03.1982en
dc.description14 p.en
dc.language.isoenen
dc.publisherWorld Health Organization
dc.publisherWorld Health Organization
dc.subject.meshInterferon-alphaen
dc.subject.otherPharmaceuticals and Biologicalsen
dc.titleThe second international standard for Lymphoblastoid Interferon, 95/568 : second evaluation studies in Japan in 2002en
dc.title.alternative2nd international standard for Lymphoblastoid Interferon, 95/568en
dc.subject.meshqualifierstandardsen


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record